A Kaiser Permanente study provides new information that may help oncologists answer one of the most common questions they hear from breast cancer survivors: Is it safe to drink alcohol?
New machine-learning method may aid personalized cancer therapy
Deep-learning technology developed by a team of Johns Hopkins engineers and cancer researchers can accurately predict cancer-related protein fragments that may trigger an immune system response. If validated in clinical trials, the technology could help scientists overcome a major hurdle to developing personalized immunotherapies and vaccines.
Video: Childhood vaccines: Moving the needle up
Childhood immunization rates around the globe are beginning to recover from the dramatic drop in routine childhood vaccination during the COVID-19 era, according to a report from the World Health Organization and UNICEF. Childhood vaccines protect kids from serious diseases and complications.
Gov’t has neglected the poor – LM Â
By SHERRY CHABALA
LEADERSHIP Movement (LM) Deputy Secretary-General, John Chandalala has accused Government of allegedly  prioritising the needs of the rich and neglecting the plight of the majority poor Zambians.
This content is locked
This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.
‘Ebb and flow’ brain mechanism that drives learning is identified
Researchers have long thought that rewards like food or money encourage learning in the brain by causing the release of the “feel-good” hormone dopamine, known to reinforce storage of new information. Now, a new study in rodents describes how learning still occurs in the absence of an immediate incentive.
Anti-bacterial virus treated antibiotic resistant infections with 86.6% success rate
A new international study conducted by the Israeli Phage Therapy Center (IPTC) led by Prof. Ran Nir-Paz at Hadassah Hebrew University Medical Center and Prof. Ronen Hazan of the Faculty of Dental Medicine at The Hebrew University of Jerusalem, using phage PASA16 on compassionate basis to treat tough Pseudomonas aeruginosa infections, has shown promising results with an 86.6% success rate.
Engineered probiotic developed to treat multiple sclerosis
Researchers from Brigham and Women’s Hospital, a founding member of the Mass General Brigham health care system, have designed a probiotic to suppress autoimmunity in the brain, which occurs when the immune system attacks the cells of the central nervous system. Autoimmunity in the brain is at the core of several diseases, including multiple sclerosis (MS).
‘Humanized’ liver in mice reveals roots of chronic diseases
Yale researchers have created a functional “humanized” liver in living mice that will help scientists find human-specific mechanisms for regulating cholesterol levels and potentially for treating chronic liver diseases afflicting tens of millions of people in the United States. The findings were published in the journal Cell.
Treatments for poxviruses—including those causing mpox and smallpox—may already exist in licensed drugs
Scientists studying how poxviruses evade natural defenses in human cells have identified a new approach to treatment that may be more durable than current treatments.
Exercise apps, a good prescription to boost health care workers’ mental health
Simple home workouts using exercise apps can effectively reduce depressive symptoms in health care workers and could be a major tool to combat the global mental health crisis in the sector, says new University of British Columbia research.